1-10 of 10
Kristoffer Hellstrand, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Remission after the First Cycle of Induction Chemotherapy Determines the Clinical Efficacy of Relapse-Preventive Immunotherapy in Acute Myeloid Leukemia

Malin S Nilsson, MSc, Alexander Hallner, PhD, Mats Brune, MD PhD, Staffan Nilsson, PhD, Fredrik B Thorén, PhD, Anna Martner, PhD, Kristoffer Hellstrand, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1318.
https://doi.org/10.1182/blood-2019-130345
Published: 2019
Journal Articles

Anti-Leukemic Properties of Histamine in Monocytic Leukemia: Role of NOX2

Roberta Kiffin, PhD, Hanna Grauers Wiktorin, Msc, Malin Nilsson, Msc, Johan Aurelius, PhD, Ebru Aydin, Msc, Brianna Lenox, Jonas Nilsson, PhD, Anders Ståhlberg, PhD, Fredrik B Thoren, Kristoffer Hellstrand, MD PhD, Anna Martner, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3818.
https://doi.org/10.1182/blood.V130.Suppl_1.3818.3818
Published: 2017
Journal Articles

Delayed Expansion of Murine BCR-ABL1 + Leukemia By Genetic and Pharmacological Inhibition of NOX2

Hanna Grauers Wiktorin, Msc, Malin Nilsson, Msc, Tina Nilsson, Msc, Johan Gustafsson, Msc, Ebru Aydin, Msc, Anders Ståhlberg, PhD, Fredrik B Thoren, Kristoffer Hellstrand, MD PhD, Lars Palmqvist, Professor, Anna Martner, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2879.
https://doi.org/10.1182/blood.V130.Suppl_1.2879.2879
Published: 2017
Journal Articles

Impact of HLA-B Dimorphism in the Leader Peptide on Clinical Outcome in AML

Alexander Hallner, Msc, Elin Bernson, Msc, Brwa Ali Hussein, MD, Frida E Sander, PhD, Mats Brune, MD, Johan Aurelius, PhD, Anna Martner, PhD, Kristoffer Hellstrand, MD PhD, Fredrik B Thoren
Journal: Blood
Blood (2017) 130 (Supplement 1): 1425.
https://doi.org/10.1182/blood.V130.Suppl_1.1425.1425
Published: 2017
Journal Articles

Reactive Oxygen Species Produced By Myeloid Cells Block CD20-Antibody Dependent NK Cell-Mediated Cytotoxicity Against Chronic Lymphocytic Leukemia Cells

Olle Werlenius, MD, Johan Aurelius, PhD, Maria Simpanen, Rebecca E Riise, Ali A Akhiani, PhD, Anna Martner, PhD, Per-Ola Andersson, MD PhD, Kristoffer Hellstrand, MD, Fredrik B Thorén, PhD
Journal: Blood
Blood (2014) 124 (21): 3638.
https://doi.org/10.1182/blood.V124.21.3638.3638
Published: 2014
Journal Articles

Natural Killer Cell Expression of Natural Cytotoxicity Receptors Determines Relapse Risk in Elderly Patients with Acute Myeloid Leukemia Receiving Immunotherapy with Histamine Dihydrochloride and Interleukin-2

Anna Martner, PhD, Anna Rydström, PhD, Rebecca E Riise, Johan Aurelius, PhD, Mats L Brune, MD, Robin Foa, MD, Kristoffer Hellstrand, MD, Fredrik B Thorén, PhD
Journal: Blood
Blood (2014) 124 (21): 3680.
https://doi.org/10.1182/blood.V124.21.3680.3680
Published: 2014
Journal Articles

Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission.

Marc E Buyse, ScD, Pierre Squifflet, MSc, Jacob M Rowe, MD, John K Whisnant, MD, Dileep Bhagwat, PhD, MBA, Stephane E Allard, MD, Kristoffer Hellstrand, MD, PhD, Mats L Brune, MD
Journal: Blood
Blood (2008) 112 (11): 1948.
https://doi.org/10.1182/blood.V112.11.1948.1948
Published: 2008
Journal Articles

Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Long Term Follow-Up of Leukemia-Free Survival and Overall Survival.

Mats L. Brune, MD, Jacob M. Rowe, MD, Jeff Szer, MD, Donna E. Hogge, MD, John Catalano, MD, Elisabeth Wallhult, RN, Bo I. Nilsson, MD, Bengt Simonsson, MD, Ruth Spearing, MD, Stephane Allard, MD, Edward A. Stadtmauer, MD, Kristoffer Hellstrand, MD
Journal: Blood
Blood (2007) 110 (11): 1846.
https://doi.org/10.1182/blood.V110.11.1846.1846
Published: 2007
Journal Articles

Impact on Quality of Life of Postconsolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myelogenous Leukemia.

Elisabeth Wallhult, RN, John Whisnant, MD, Jacob M. Rowe, MD, Jeff Szer, MD, Dileep Bhagwat, PhD, Kristoffer Hellstrand, MD, Bo I. Nilsson, MD, Mats L. Brune, MD
Journal: Blood
Blood (2007) 110 (11): 4381.
https://doi.org/10.1182/blood.V110.11.4381.4381
Published: 2007
Journal Articles

Improved Leukemia-Free Survival after Post-Consolidation Treatment with Histamine Dihydrochloride and Interleukin-2 in AML: A Randomized Phase III Trial.

Mats Brune, MD, Sylvie Castaigne, MD, John Catalano, MD, Kurt Gehlsen, PhD, Wolf-Karsten Hofmann, MD, Anthony Ho, MD, Donna Hogge, MD, Bo Nilsson, MD, Reuven Or, MD, Jacob Rowe, MD, Bengt Simonsson, MD, Ruth Spearing, MD, Edward Stadtmauer, MD, Jeff Szer, MD, Elisabeth Wallhult, RN, Kristoffer Hellstrand, MD
Journal: Blood
Blood (2004) 104 (11): 261.
https://doi.org/10.1182/blood.V104.11.261.261
Published: 2004